Neovasc (NVCN) Stock Forecast, Price & News

Neovasc (NASDAQ:NVCN) Frequently Asked Questions

Is Neovasc a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neovasc in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Neovasc stock.
View analyst ratings for Neovasc or view top-rated stocks.

Are investors shorting Neovasc?

Neovasc saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 5,300 shares, a decline of 76.8% from the April 30th total of 22,800 shares. Based on an average trading volume of 13,500 shares, the short-interest ratio is presently 0.4 days.
View Neovasc's Short Interest.

When is Neovasc's next earnings date?

Neovasc is scheduled to release its next quarterly earnings announcement on Tuesday, August 9th 2022.
View our earnings forecast for Neovasc.

How were Neovasc's earnings last quarter?

Neovasc Inc. (NASDAQ:NVCN) posted its quarterly earnings data on Thursday, March, 10th. The medical equipment provider reported ($2.25) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.50) by $0.25. The medical equipment provider earned $0.76 million during the quarter, compared to the consensus estimate of $0.80 million. Neovasc had a negative trailing twelve-month return on equity of 50.69% and a negative net margin of 1,192.20%.
View Neovasc's earnings history.

When did Neovasc's stock split? How did Neovasc's stock split work?

Shares of Neovasc reverse split on Friday, April 29th 2022. The 1-25 reverse split was announced on Friday, April 29th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 29th 2022. An investor that had 100 shares of Neovasc stock prior to the reverse split would have 4 shares after the split.

What price target have analysts set for NVCN?

1 Wall Street analysts have issued 12-month target prices for Neovasc's stock. Their forecasts range from $125.00 to $125.00. On average, they anticipate Neovasc's share price to reach $125.00 in the next twelve months. This suggests a possible upside of 2,062.6% from the stock's current price.
View analysts' price targets for Neovasc or view top-rated stocks among Wall Street analysts.

Who are Neovasc's key executives?

Neovasc's management team includes the following people:

• Mr. Fredericus A. Colen, Pres, CEO & Director (Age 70, Pay $2.59M)
• Mr. Christopher Clark B.A., BA (Honours), C.A., CA, PgD, CFO & Corp. Sec. (Age 50, Pay $1.13M)
• Mr. William Reed Little, Chief Operating Officer (Age 50, Pay $1.2M)
• Mr. John Christopher Panton, Chief Quality Officer (Age 55, Pay $401.67k)
• Sarah Marie-Hodgson Gallagher, VP of Clinical Affairs

Who are some of Neovasc's key competitors?

Some companies that are related to Neovasc include Biostage (BSTG), Pro-Dex (PDEX), Titan Medical (TMDI), Spectral Medical (EDTXF), TransEnterix (TRXC), Daxor (DXR), Venus Concept (VERO), SANUWAVE Health (SNWV), Integrity Applications (IGAP), GlucoTrack (GCTK), Isoray (ISR), Isoray (ISR), enVVeno Medical (NVNO), STRATA Skin Sciences (SSKN) and Delcath Systems (DCTH).
View all of NVCN's competitors.

What other stocks do shareholders of Neovasc own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neovasc investors own include Biopharmx (BPMX), Allstate (ALL), Amicus Therapeutics (FOLD), Synergy Pharmaceuticals (SGYP), Rexahn Pharmaceuticals (REXN), Heat Biologics (HTBX), Protalix BioTherapeutics (PLX), Palatin Technologies (PTN), (XXII) and Amarin (AMRN).

What is Neovasc's stock symbol?

Neovasc trades on the NASDAQ under the ticker symbol "NVCN."

How do I buy shares of Neovasc?

Shares of NVCN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Neovasc's stock price today?

One share of NVCN stock can currently be purchased for approximately $5.78.

How much money does Neovasc make?

Neovasc has a market capitalization of $15.65 million and generates $2.55 million in revenue each year. The medical equipment provider earns $-24.89 million in net income (profit) each year or ($12.00) on an earnings per share basis.

How many employees does Neovasc have?

Neovasc employs 49 workers across the globe.

What is Neovasc's official website?

The official website for Neovasc is www.neovasc.com.

How can I contact Neovasc?

Neovasc's mailing address is Suite 5138 - 13562 Maycrest Way, RICHMOND A1, V6V 2J7. The medical equipment provider can be reached via phone at (604) 270-4344, via email at [email protected], or via fax at 604-270-4384.